Brainsway (BWAY) EBIT Margin (2018 - 2026)
Brainsway (BWAY) posted quarterly EBIT Margin of 12.91% for Q1 2026, up 792.0% year-on-year from 1.45% in Q1 2025, and down 2.0% on a QoQ basis from 13.17% in Q4 2025.
Brainsway (BWAY) EBIT Margin (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported EBIT Margin for 9 consecutive years, with 12.91% the latest figure, recorded in Q1 2026.
- Quarterly EBIT Margin rose 792.0% year-over-year to 12.91% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 10.23% (up 592.0% YoY) and the FY2025 annual result came in at 8.28%, up 489.0% from the prior year.
- EBIT Margin retreated to 12.91% in Q1 2026 per BWAY's latest filing, from 13.17% in the prior quarter.
- Over the last five years, EBIT Margin for BWAY reached as high as 13.17% in Q4 2025 and fell as low as 94.23% in Q3 2022.
- A 5-year average of 13.14% and a median of 2.04% in 2023 frame the typical range for EBIT Margin.
- Annual changes were most pronounced in 2022 — EBIT Margin slumped 7894 bps — and 2023, when it jumped 9263 bps.
- Year by year, EBIT Margin stood at 71.66% in 2022, then soared by 103 bps to 2.04% in 2023, then soared by 85 bps to 3.78% in 2024, then jumped by 249 bps to 13.17% in 2025, then retreated by 2 bps to 12.91% in 2026.
- According to Business Quant data, EBIT Margin over the past three periods registered 12.91%, 13.17%, and 9.27% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | 12.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.91% |
| Dec 31, 2025 | 13.17% |
| Sep 30, 2025 | 9.27% |
| Jun 30, 2025 | 4.58% |
| Mar 31, 2025 | 4.99% |
| Dec 31, 2024 | 3.78% |
| Sep 30, 2024 | 2.68% |
| Jun 30, 2024 | 5.86% |
| Mar 31, 2024 | 1.02% |
| Dec 31, 2023 | 2.04% |
| Sep 30, 2023 | -1.60% |
| Jun 30, 2023 | -17.15% |
| Mar 31, 2023 | -55.35% |
| Dec 31, 2022 | -71.66% |
| Sep 30, 2022 | -94.23% |
| Jun 30, 2022 | -25.08% |
| Mar 31, 2022 | -18.59% |
| Dec 31, 2021 | -17.14% |
| Sep 30, 2021 | -15.30% |
| Jun 30, 2021 | -21.60% |